Through AI, computational pathology, clinical expertise, and capital investors we will change how to diagnose cancer and guide therapy
At the heart of PAIGE are large-scale machine learning algorithms that are trained at petabyte-scale from tens of thousands of digital slides. We are developing novel deep learning algorithms based on convolutional and recurrent neural networks as well as generative models that are able to learn efficiently from an unprecedented wealth of visual and clinical data.
Digitized slides paired with clinical notes and machine learning algorithms will enable pathologists to reach diagnoses faster and more accurately.
Medical AI at an unprecedented scale
PAIGE has a comprehensive license with MSK and exclusive rights to their library of 25 million pathology slides — one of the largest tumor pathology archives. PAIGE plans to build on to MSK's efforts and digitize millions of archived slides. This digital treasure, along with anonymized clinical data, allows us to train models at scale.
Our data is enriched by an unmatched repository of annotated pathology slides, diagnosed by the world’s leading pathologists.
Investing for growth and leadership
As investors pour millions of dollars into startups applying artificial intelligence to medicine, pathology is at the forefront of what can be achieved, and we are the charge. We are backed by $25 million series A financing.
CEO, Jim Breyer Capital
What's happening at PAIGE?
Learn about our technology and how PAIGE is revolutionizing pathology.Our Product